Zdrowie i gospodarka · 20/02/2002

FDA Clears Azathioprine 25mg Tablets for Approval, Rejecting Withdrawal Claims

The US Food and Drug Administration (FDA) has made a determination that azathioprine 25mg tablets, marketed under the brand name Imuran, were not withdrawn from sale due to safety or effectiveness concerns, paving the way for the approval of abbreviated new drug applications (ANDAs) for these tablets.